![](/img/cover-not-exists.png)
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC)
Purshouse, K., Woodcock, V.K., Butcher, C., Haddon, C., Verrall, G., Elhussein, L., Salio, M., Middleton, M.R., Cerundolo, V., Kwok, J., Blagden, S., Protheroe, A.S., Crew, J.Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(19)30564-0
Date:
March, 2019
File:
PDF, 87 KB
2019